Once- or twice-daily dosing of nevirapine in HIV-infected adults: a population pharmacokinetics approach.

MLA

Moltó, José, et al. “Once- or Twice-Daily Dosing of Nevirapine in HIV-Infected Adults: A Population Pharmacokinetics Approach.” The Journal of Antimicrobial Chemotherapy, vol. 62, no. 4, Oct. 2008, pp. 784–92. EBSCOhost, https://doi.org/10.1093/jac/dkn268.

APA

Moltó, J., Valle, M., Miranda, C., Cedeño, S., Miranda, J., Santos, J. R., Negredo, E., Vilaró, J., Costa, J., & Clotet, B. (2008). Once- or twice-daily dosing of nevirapine in HIV-infected adults: a population pharmacokinetics approach. The Journal of Antimicrobial Chemotherapy, 62(4), 784–792. https://doi.org/10.1093/jac/dkn268

Chicago

Moltó, José, Marta Valle, Cristina Miranda, Samandhy Cedeño, José Miranda, José Ramón Santos, Eugenia Negredo, Josep Vilaró, Joan Costa, and Bonaventura Clotet. 2008. “Once- or Twice-Daily Dosing of Nevirapine in HIV-Infected Adults: A Population Pharmacokinetics Approach.” The Journal of Antimicrobial Chemotherapy 62 (4): 784–92. doi:10.1093/jac/dkn268.